Focused peptide library screening as a route to a superior affinity ligand for antibody purification.
Alcohols
/ chemistry
Amino Acid Sequence
Chromatography, Affinity
/ methods
Directed Molecular Evolution
/ methods
High-Throughput Nucleotide Sequencing
High-Throughput Screening Assays
Humans
Immunoglobulin Fc Fragments
/ chemistry
Immunoglobulin G
/ chemistry
Ligands
Peptide Library
Protein Binding
Sepharose
/ chemistry
Staphylococcal Protein A
/ chemistry
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
02 06 2021
02 06 2021
Historique:
received:
09
04
2021
accepted:
24
05
2021
entrez:
3
6
2021
pubmed:
4
6
2021
medline:
6
11
2021
Statut:
epublish
Résumé
Affinity chromatography is the linchpin of antibody downstream processing and typically relies on bacterial immunoglobulin (Ig)-binding proteins, epitomized by staphylococcal protein A-based ligands. However, such affinity ligands are fairly costly and suffer from chemical instability, leading to ligand denaturation and leaching from chromatographic support. Innovations in this area are aimed at developing robust and highly selective antibody ligands capable of withstanding harsh column sanitization conditions. We report the development and first-stage characterization of a selective short linear peptide ligand of the IgG Fc region capable of capturing all four IgG subclasses. The ligand was discovered through in vitro directed evolution. A focused phage-display library based on a previously identified peptide lead was subjected to a single-round screen against a pool of human IgG. The hits were identified with next-generation sequencing and ranked according to the enrichment ratio relative to their frequency in the pre-screened library. The top enriched peptide GSYWYNVWF displaying highest affinity for IgG was coupled to bromohydrin-activated agarose beads via a branched linker. The resulting affinity matrix was characterized with a dynamic binding capacity of approx. 43 mg/mL, on par with commercially employed protein A-based resin.
Identifiants
pubmed: 34079028
doi: 10.1038/s41598-021-91208-0
pii: 10.1038/s41598-021-91208-0
pmc: PMC8173005
doi:
Substances chimiques
Alcohols
0
Immunoglobulin Fc Fragments
0
Immunoglobulin G
0
Ligands
0
Peptide Library
0
Staphylococcal Protein A
0
bromohydrins
0
Sepharose
9012-36-6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
11650Références
Int J Mol Sci. 2019 Dec 27;21(1):
pubmed: 31892275
Bioconjug Chem. 2019 Mar 20;30(3):815-825
pubmed: 30653289
Methods Mol Biol. 2007;378:33-52
pubmed: 18605076
Bioconjug Chem. 2017 Aug 16;28(8):2009-2030
pubmed: 28696676
J Chromatogr A. 2021 Jan 4;1635:461632
pubmed: 33333349
Bioconjug Chem. 2018 Aug 15;29(8):2763-2775
pubmed: 30024737
Chem Biol Drug Des. 2019 May;93(5):724-736
pubmed: 30582286
Biotechnol Bioeng. 2013 Mar;110(3):857-70
pubmed: 23108907
J Mol Recognit. 1996 Sep-Dec;9(5-6):564-9
pubmed: 9174941
Biotechnol Prog. 2016 Sep;32(5):1193-1202
pubmed: 27390273
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Mar 15;848(1):48-63
pubmed: 17134947
J Mol Biol. 1990 Mar 20;212(2):295-318
pubmed: 2157024
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Mar 15;848(1):8-18
pubmed: 16899415
Bioinformatics. 2011 Mar 15;27(6):863-4
pubmed: 21278185
Curr Pharm Des. 2011;17(25):2732-47
pubmed: 21728985
Bioconjug Chem. 2016 Jul 20;27(7):1569-73
pubmed: 27362542
J Chromatogr A. 2010 Jan 8;1217(2):216-24
pubmed: 19819462
Genome Res. 2019 Jun;29(6):961-968
pubmed: 31048319
Anal Biochem. 2014 Oct 1;462:35-43
pubmed: 24952360
Biochemistry. 2017 Jan 24;56(3):445-457
pubmed: 28029249
Int J Mol Sci. 2019 Jan 04;20(1):
pubmed: 30621158
Front Microbiol. 2017 Mar 28;8:495
pubmed: 28400756
Nucleic Acids Res. 2014 Dec 16;42(22):e169
pubmed: 25348396
J Chromatogr A. 2012 Feb 17;1225:158-67
pubmed: 22251884